NEFFY Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Neffy, and when can generic versions of Neffy launch?

Neffy is a drug marketed by Ars Pharms Operation and is included in one NDA. There are seven patents protecting this drug.

This drug has seventy patent family members in twenty-eight countries.

The generic ingredient in NEFFY is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Neffy

A generic version of NEFFY was approved as epinephrine by BPI LABS on July 29^th, 2014.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NEFFY?
What are the global sales for NEFFY?
What is Average Wholesale Price for NEFFY?

Summary for NEFFY

International Patents:	70
US Patents:	7
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in NEFFY?	NEFFY excipients list
DailyMed Link:	NEFFY at DailyMed

Drug patent expirations by year for NEFFY

Pharmacology for NEFFY

Drug Class	Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Adrenergic beta-Agonists

US Patents and Regulatory Information for NEFFY

NEFFY is protected by seven US patents.

Patents protecting NEFFY

Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Intranasal epinephrine formulations and methods for the treatment of disease
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Compositions for drug administration
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ars Pharms Operation	NEFFY	epinephrine	SPRAY;NASAL	214697-001	Aug 9, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for NEFFY

See the table below for patents covering NEFFY around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Poland	3678649		⤷ Sign Up
Lithuania	3678649		⤷ Sign Up
Eurasian Patent Organization	202091615	ИНТРАНАЗАЛЬНЫЕ СОСТАВЫ НА ОСНОВЕ ЭПИНЕФРИНА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ	⤷ Sign Up
China	116549389	鼻内肾上腺素制剂及治疗疾病的方法 (Intranasal epinephrine formulations and methods of treating diseases)	⤷ Sign Up
Australia	2011317202	Compositions for drug administration	⤷ Sign Up
South Korea	101719008		⤷ Sign Up
Japan	5752048		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for NEFFY

Pharmacology for NEFFY

Patents protecting NEFFY

Make Better Decisions: Try a trial or see plans & pricing